Twist Bioscience Corporation
TWST
$29.70
-$0.16-0.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -233.09% | 151.85% | -24.48% | 8.83% | 59.50% |
| Total Depreciation and Amortization | -48.82% | -5.29% | 0.38% | 57.30% | -51.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 151.53% | -249.53% | 76.75% | -13.37% | -76.31% |
| Change in Net Operating Assets | -284.59% | 409.83% | 85.08% | -617.98% | -109.07% |
| Cash from Operations | -743.86% | 89.22% | 39.40% | -39.87% | -140.20% |
| Capital Expenditure | -35.59% | -121.16% | -82.72% | -13.29% | -107.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | 100.88% | -200.52% | 271.31% | 2.09% | 182.28% |
| Cash from Investing | -31.99% | -558.98% | 7.16% | -19.53% | -80.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 204.87% | -42.86% | 8.51% | -18.84% | 24.70% |
| Repurchase of Common Stock | 33.33% | 40.00% | 16.67% | 25.00% | -14.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | 205.26% | -42.87% | -82.19% | 394.73% | 24.72% |
| Foreign Exchange rate Adjustments | 329.58% | -168.27% | 296.23% | -172.60% | 3,550.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.38% | 18.63% | -119.04% | 60.69% | -208.81% |